ST
TCRT icon

Spot Trading’s Alaunos Therapeutics TCRT Stock Holding History

Spot Trading’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$76K Buy
+83
New +$73.7K ﹤0.01% 2636
2017
Q1 		– Sell
-82
Closed -$66K – 3303
2016
Q4 		$66K Buy
82
+26
+46% +$23.4K ﹤0.01% 2340
2016
Q3 		$48K Sell
56
-77
-58% -$61.9K ﹤0.01% 2629
2016
Q2 		$109K Buy
133
+122
+1,109% +$133K ﹤0.01% 2500
2016
Q1 		$13K Sell
11
-54
-83% -$55.3K ﹤0.01% 3098
2015
Q4 		$81K Buy
65
+36
+124% +$59.5K ﹤0.01% 2888
2015
Q3 		$39K Hold
29
– – ﹤0.01% 3337
2015
Q2 		$52K Buy
29
+12
+71% +$18.6K ﹤0.01% 3273
2015
Q1 		$28K Buy
17
+9
+113% +$13.3K ﹤0.01% 3440
2014
Q4 		$6K Sell
8
-71
-90% -$37.7K ﹤0.01% 3742
2014
Q3 		$31K Buy
+79
New +$38.1K ﹤0.01% 3879

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Spot Trading's TCRT Position: Q3 2017 in Review

Spot Trading opened a new position in Alaunos Therapeutics (TCRT) in Q3 2017: 83 shares worth $76K. The stake represents ﹤0.01% of the portfolio and ranks #2636 among its holdings. This is a return to the name: Spot Trading previously reported a position in TCRT as recently as Q4 2016.

Spot Trading first reported a position in TCRT in Q3 2014 and has held it in 11 quarters since. The position peaked at $109K in Q2 2016. 122 funds tracked by Wall St. Rank hold TCRT as of Q3 2017.

  • Spot Trading held 83 shares of Alaunos Therapeutics worth $76K as of Q3 2017.
  • Alaunos Therapeutics was a new Spot Trading position in Q3 2017.
  • Alaunos Therapeutics made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2636 holding.
  • Spot Trading first reported a position in Alaunos Therapeutics in Q3 2014 and has held it in 11 quarters since.
  • Spot Trading's Alaunos Therapeutics position peaked at $109K in Q2 2016.
  • 122 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.